Important Notice
- Hunan Qianshan Pharmaceutical Machinery Co., Ltd. (hereinafter referred to as "Qianshan Pharmaceutical" or "the Company") has had its stock suspended from trading prior to the implementation of the "Shenzhen Stock Exchange GEM Stock Listing Rules (Revised in 2020)" and is subject to the delisting provisions of the "Shenzhen Stock Exchange GEM Stock Listing Rules (Revised in November 2018)."
- Regarding the temporary suspension of the Company's stock: Due to the Company's audited net assets being negative at the end of 2018, and both the 2017 and 2018 annual financial reports receiving audit reports from registered accountants that could not express an opinion, the Shenzhen Stock Exchange decided to suspend the trading of the Company's stock (stock abbreviation "Qianshan Pharmaceutical," stock code "300216") starting from May 13, 2019, based on the provisions of Articles 13.1.1 and 13.1.5 of the "Shenzhen Stock Exchange GEM Stock Listing Rules (Revised in November 2018)" and the review opinions of the Shenzhen Stock Exchange Listing Committee.
- Regarding the risk of the Company's stock being delisted: According to Article 13.4.1 of the "Shenzhen Stock Exchange GEM Stock Listing Rules (Revised in November 2018)," if a listed company experiences any of the following situations, the Exchange has the right to decide to terminate its stock listing: "(2) If the net profit or net profit after deducting non-recurring gains and losses for the first year after the suspension is negative; (3) If the net assets at the end of the first year after the suspension are negative; (5) If the financial report for the first year after the suspension receives an audit report with a qualified opinion, inability to express an opinion, or a negative opinion." The Company and all members of the Board of Directors guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
- The Company's 2019 Annual Report and 2019 Audit Report disclosed on June 30, 2020, show: (1) Lianda Accounting Firm (Special General Partnership) issued an audit report with an inability to express an opinion for the Company's 2019 financial report; (2) The net assets attributable to shareholders of the listed company for 2019 were approxim